Moderna Biotech Spain, S.L.
4 products tracked · names used in filings: Moderna Biotech Spain, S.L.
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Mon 20 Apr 2026🇪🇺 EU approval (EC decision)
mCombriax (influenza mRNA vaccine;COVID-19 mRNA vaccine) approved in the EU
Marketing authorisation to Moderna Biotech Spain, S.L.; Additional monitoring · source
Thu 26 Feb 2026🇪🇺 CHMP positive opinion
mCombriax (influenza mRNA vaccine;COVID-19 mRNA vaccine): CHMP positive opinion
Moderna Biotech Spain, S.L.; Additional monitoring · source
Thu 12 Feb 2026🇪🇺 EU approval (EC decision)
mNexspike (COVID-19 mRNA vaccine) approved in the EU
Marketing authorisation to Moderna Biotech Spain, S.L.; Additional monitoring · source
Thu 11 Dec 2025🇪🇺 CHMP positive opinion
mNexspike (COVID-19 mRNA vaccine): CHMP positive opinion
Moderna Biotech Spain, S.L.; Additional monitoring · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | mCombriax influenza mRNA vaccine;COVID-19 mRNA vaccine | Authorised | 2026-04-20 |
| 🇪🇺 | mNexspike COVID-19 mRNA vaccine | Authorised | 2026-02-12 |
| 🇪🇺 | mResvia respiratory syncytial virus mRNA vaccine | Authorised | 2024-08-22 |
| 🇪🇺 | Spikevax (previously COVID-19 Vaccine Moderna) COVID-19 mRNA vaccine | Authorised | 2021-01-06 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.